Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Covalon Technologies Ltd CVALF


Primary Symbol: V.COV

Healthcare Biotechnology
Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold... see more

Recent & Breaking News (TSXV:COV)

Covalon Announces Leadership Changes

Business Wire September 26, 2023

Life with a Central Line [WEBINAR]: Key Considerations from the Patient's Perspective

Business Wire September 25, 2023

Covalon Showcases Compassionate Pediatric Care Solutions at 47th APHON Conference

Business Wire September 19, 2023

Covalon Announces Third Quarter Fiscal 2023 Results

Business Wire August 16, 2023

Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2023 Financial Results

Business Wire August 14, 2023

Premier Medical Journal Spotlights Covalon's VALGUARD: A Novel Solution to Long-Standing Problem of Protecting Vascular Access Sites

Business Wire July 18, 2023

Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 - 30, 2023

Business Wire June 27, 2023

Covalon Announces Participation in APIC Annual Conference & Exposition on June 26 - 28, 2023 in Orlando, Florida

Business Wire June 26, 2023

Webinar on Addressing MARSI in Vascular Access: The Role of Skin Integrity in Infection Prevention, Presented by Covalon

Business Wire June 21, 2023

Breakthrough Solution for Fragile Skin: Covalon's IV Clear® Dressing Recommended by Physicians at a Top 10 U.S. Children's Hospital and Epidermolysis Bullosa Center of Excellence

Business Wire June 13, 2023

Covalon Announces Second Quarter Results for Fiscal 2023

Business Wire May 25, 2023

Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2023 Financial Results

Business Wire May 23, 2023

Covalon, Leader in Compassionate Pediatric Infection Prevention Solutions, to Participate in Neonatal/Fetal Conference in Columbus, Ohio on May 17 - 19, 2023

Business Wire May 16, 2023

Compassionate Care Solutions Provider Covalon Participating in the Canadian Vascular Access Association and World Congress on Vascular Access Joint Conference on April 26-28, 2023 in Toronto

PR Newswire April 26, 2023

Covalon Presents New CLABSI Conscious Series Webinar: Protecting CVADs from Gross Contamination

PR Newswire March 27, 2023

Leader in Compassionate Care Infection Prevention Solutions, Covalon, to Participate in the Synova NICU Leadership Forum 2023 in Tucson, Arizona from March 19 to 23, 2023

PR Newswire March 20, 2023

Covalon Announces Voting Results from Fiscal 2022 Annual and Special Meeting of Shareholders

PR Newswire March 9, 2023

Covalon Welcomes Martin Goldfarb, O.C., to its Board of Directors

PR Newswire March 9, 2023

Covalon To Hold Annual and Special Meeting of Shareholders on Wednesday, March 8, 2023

PR Newswire February 28, 2023

Covalon Announces Improved First Quarter Fiscal 2023 Results

PR Newswire February 23, 2023